First Implant of KingstronBio’s ProStyle M® Transcatheter Mitral Valve System Successfully Completed in National Multicenter Confirmatory Studynews2026-04-08T15:07:19+00:00April 8th, 2026|Medical Device News Magazine|
Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shocknews2026-04-08T15:03:48+00:00April 8th, 2026|Medical Device News Magazine|
Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retentionnews2026-04-06T13:42:45+00:00April 6th, 2026|Medical Device News Magazine|
Complement Therapeutics Announces First Patient Dosed with CTx001 in the Phase I/II Opti-GAIN Study for Geographic Atrophy Secondary to AMDnews2026-03-25T09:55:33+00:00March 25th, 2026|Medical Device News Magazine|
Innovative Medical Equipment, LLC Highlights Published VA Clinical Study on Thermal Therapy and Pain Treatment Utilizationnews2026-03-20T00:44:24+00:00March 20th, 2026|Medical Device News Magazine|
Results from PARADIGM Phase 2b Trial of PrimeC in ALS Demonstrating Meaningful Clinical Outcomes and Biological Activity Published in JAMA Neurologynews2026-03-16T16:22:20+00:00March 16th, 2026|Medical Device News Magazine|
Verve Medical Treats First Patient in Landmark U.S. Pilot Trial for Uncontrolled Hypertension, Advancing Momentum from Breakthrough TUSK Resultsnews2026-03-11T15:24:16+00:00March 11th, 2026|Medical Device News Magazine|
MBX Biosciences Announces Successful End-of-Phase 2 FDA Meeting and Provides Phase 3 Development Plan for Once-Weekly Canvuparatide for Hypoparathyroidismnews2026-03-09T16:09:30+00:00March 9th, 2026|Medical Device News Magazine|
Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Datasetnews2026-03-09T15:11:27+00:00March 9th, 2026|Medical Device News Magazine|
Medicus Pharma reports positive Phase 2 SKNJCT-003 Topline Data observing 73% Clinical Clearance and 40% Histological Clearance at day 57news2026-03-05T14:17:29+00:00March 5th, 2026|Medical Device News Magazine|
